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Abstract
 
Variable/diversity/joining (V[D]J) recombination of the T cell receptor (TCR) and immuno-
globulin (Ig) genes is regulated by chromatin accessibility of the target locus to the recombinase
in a lineage- and stage-specific manner. Histone acetylation has recently been proposed as a
molecular mechanism underlying the accessibility control. Here, we investigate the role for his-
tone acetylation in the developmentally regulated rearrangements of the mouse TCR-
 
g
 
 gene,
wherein predominant rearrangement is switched from V
 
g
 
3 to V
 
g
 
2 gene during the fetal to
adult thymocyte development. Our results indicate that histone acetylation correlates with ac-
cessibility, as histone acetylation at the fetal-type V
 
g
 
3 gene in accord with germline transcrip-
tion is relatively high in fetal thymocytes, but specifically becomes low in adult thymocytes
within the entirely hyperacetylated locus. Furthermore, inhibition of histone deacetylation
during the development of adult bone marrow–derived thymocytes by a specific histone
deacetylase inhibitor, trichostatin A, leads to elevated histone acetylation, germline transcrip-
tion, cleavage, and rearrangement of the V
 
g
 
3 gene. These data demonstrate that histone acetyl-
ation functionally determines the chromatin accessibility for V(D)J recombination in vivo and
that an epigenetic modification of chromatin plays a direct role in executing a developmental
switch in cell fate determination.
Key words: V(D)J recombination • germline transcript • ligation-mediated PCR • chromatin 
immunoprecipitation • histone deacetylase
 
Introduction
 
Lymphocyte development is regulated by V(D)J recom-
bination that assembles V, D, and J gene segments in the
TCR and Ig loci. V(D)J recombination reaction is cata-
lyzed by the common enzymatic machinery that includes
recombination activating gene (RAG)-1 and RAG-2 pro-
teins (1, 2). RAG-1 and RAG-2 recognize recombination
signal sequences (RSSs) that flank all the coding gene seg-
ments and then introduce cleavages of DNA at RSSs.
Lymphocyte-specific recombination is primarily ensured
by the restriction of RAG-1 and RAG-2 expression to
defined stages of T and B lymphoid development. How-
ever, lineage- and stage-specificity of the rearrangements
is regulated by the accessibility of RSSs within chromatin
to the recombinase (3–5). Recent studies revealed that
the cis-acting elements within TCR and Ig loci including
enhancers and promoters play crucial roles in recombina-
tion by establishing the locus- and gene segment–specific
accessibility (3–5). However, the molecular nature of
chromatin structural modifications responsible for accessi-
bility has long been unknown. Acetylation of the NH
 
2
 
-
terminal tails of histones, the most extensively character-
ized modification of chromatin, has been implicated for
transcriptional regulation through the alteration of chro-
matin structure (6, 7). Recently, acetylation of histone
H3 was shown to tightly correlate with locus-wide acces-
sibility for V(D)J recombination directed by the enhancer
in vivo (8), suggesting that histone acetylation might be
functionally relevant to the accessibility control.
In this report, we investigate the role for histone acetyla-
tion in the accessibility control during the physiological thy-
mocyte development. We focused on the mouse TCR-
 
g
 
gene
 
 
 
(9, 10), wherein rearrangement of V
 
g
 
3 gene is re-
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stricted to fetal stages, whereas V
 
g
 
2 recombination predom-
inates in the adult thymus
 
 
 
(11–13). Our data demonstrate
that targeted histone deacetylation is responsible for the in-
hibition of V
 
g
 
3 rearrangements in adult thymocytes.
 
Materials and Methods
 
Cell Preparation, Fetal Thymic Organ Culture, and Flow Cytome-
try.
 
Fetal and adult thymocytes were prepared from embryonic
day 14 (E14) and E16 C57BL/6 fetuses and 4-wk-old C57BL/6
mice. CD3
 
2
 
CD4
 
2
 
CD8
 
2
 
CD19
 
2
 
TER119
 
2 
 
thymocytes were iso-
lated by MACS (Miltenyi Biotec) and used as CD3
 
2
 
CD4
 
2
 
CD8
 
2
 
triple negative (TN) thymocytes. We routinely obtained the pop-
ulation of 
 
.
 
95% purity. Fetal thymic organ culture (FTOC) was
performed as described (14, 15). Fetal liver cells of E14 C57BL/6
fetuses and adult bone marrow cells of 8-wk-old C57BL/6 mice
(2 
 
3 
 
10
 
5 
 
cells/lobe) were transferred into 2
 
9
 
-deoxyguanosine–
treated E15 fetal thymic lobes from ICR mice in a hanging drop
for 24 h, and then organ cultured on a floating Nucleopore poly-
carbonate filter (Corning) with trichostatin A
 
 (
 
TSA; 3 ng/ml;
WAKO) or equal volume of DMSO as a vehicle control. Flow
cytometric analysis was performed as described (14, 15). The fol-
lowing monoclonal antibodies were used: FITC-conjugated anti-
CD3
 
e
 
 (145-2C11) and anti-V
 
g
 
2 (UC3-10A6) antibodies; and
PE-conjugated anti-CD3
 
e
 
 (145-2C11) and anti-V
 
g
 
3 (536) anti-
bodies (BD PharMingen). Viable cells were analyzed by a FACS-
Calibur™ with CELLQuest™ software v3.1 (Becton Dickinson).
 
PCR Analysis.
 
Genomic DNA was prepared by the standard
proteinase K method (16). Fivefold serial dilutions (50, 10, and 2
ng) of fetal and adult thymocyte DNAs were prepared in 25 
 
m
 
g/
ml sonicated pBSKS. Diluted DNA and organ-cultured thy-
mocyte DNA (equivalent to 10
 
3
 
 cells) were analyzed by PCR in
10 
 
m
 
l reaction with 0.25 mM dNTP, 0.5 
 
m
 
M each primer, 5 
 
m
 
g/
ml sonicated pBSKS, and 0.5 U of rTaq DNA polymerase
(Takara). PCR was performed for 24, 28, or 32 cycles (CD3
 
e
 
,
V
 
g
 
 coding joints, V
 
g
 
 signal joints, respectively) of 94
 
8
 
C, 45 s,
55
 
8
 
C, 120 s, and 72
 
8
 
C, 60 s with the following primers: CD3
G1/2 F141, 5
 
9
 
-TCAAAGGCCAGGACGGCTAC-3
 
9
 
; CD3
G1/2 R636, 5
 
9
 
-GCCATAGTAGGATGAAGGAG-3
 
9
 
; for V
 
g
 
coding joints, L2, L3 (13), and STP100 (J
 
g
 
1 [17]); for V
 
g
 
 signal
joints, V2S-R1, 5
 
9
 
-GGAGTGATTCAGGGGATTCA-3
 
9
 
, V3S-
R1, 5
 
9
 
-TGACATCCTTGAACCGAGTC-3
 
9
 
, and J1P-F1, 5
 
9
 
-
ACAGTTTCAACACGAGTGAG-3
 
9
 
. PCR products were run
on a 2% agarose gel, transferred to HybondN
 
1
 
 membrane (Am-
ersham Pharmacia Biotech), and hybridized with 
 
32
 
P-end-labeled
oligonucleotide probe as follows: CD3 G1/2 F443, 5
 
9
 
-GGC-
CCGGATTTCCTCAGTTA-3
 
9
 
; for V
 
g
 
 coding joints, STS1008
(J
 
g
 
1 [17]); for V
 
g
 
 signal joints, V2-3
 
9
 
b and V3-3
 
9
 
b (13). All the
Southern blots were analyzed and quantitated using a Bio-image
Analyzer (Fujix BAS5000).
 
Ligation-mediated PCR.
 
The same set of the genomic DNAs
was analyzed by ligation-mediated PCR as described (18). Fetal
and adult thymocyte DNA (10 ng) and organ-cultured thy-
mocyte DNA (equivalent to 2 
 
3 
 
10
 
3
 
 cells) were ligated to an-
nealed BW linker. Ligated DNA was amplified for 12 cycles with
the BW-1H primer and the following distal locus-specific primer:
3
 
9
 
V
 
g
 
2 3
 
9
 
-1, 5
 
9
 
-CATTCAGCAGGAAACAGTGCTAACCAG-
3
 
9
 
; V
 
g
 
3EXT (19). The first PCR product was then amplified for
30 cycles with the following linker- and proximal locus–specific
primers: for V
 
g
 
2, BW-1H5, 5
 
9
 
-ACCCGGGAGATCTGAAT-
TCCACAGCA-3
 
9
 
, 3
 
9
 
V
 
g
 
2 3
 
9
 
-2, 5
 
9
 
-TGATAGCAAGATAGTC-
CCTGAGGCT-3
 
9
 
; for V
 
g
 
3, BW-1H3, 5
 
9
 
-ACCCGGGAGAT-
 
CTGAATTCCACAGT-3
 
9
 
, V
 
g
 
3INT (19). PCR products were
analyzed by Southern blotting using the V2-3
 
9
 
b and V3-3
 
9
 
b oli-
gonucleotides as probes.
 
Reverse Transcription PCR.
 
Total RNA was prepared using
TRIzol (GIBCO BRL). Random hexamer-primed cDNA was
synthesized from RNA equivalent to 2–6 
 
3
 
 10
 
4
 
 cells using
Moloney murine leukemia virus (MMLV) reverse-transcriptase
Superscript II (GIBCO BRL) according to the manufacturer’s in-
structions. Fivefold serial dilutions of cDNA (equivalent to 5, 1,
and 0.2 
 
3 
 
10
 
3
 
 cells) were amplified as in genomic PCR with the
following primers: for V
 
g
 
2 germline transcript (GLT), LV2, 5
 
9
 
-
TCTTATGCCTCTTGACATTTGG-3
 
9
 
, V2-3
 
9
 
a (13); for V
 
g
 
3
GLT, LV3, 5
 
9
 
-TGTCTTTGACCTGTGTTTATGG-3
 
9
 
, V3-3
 
9
 
a
(13); for J
 
g
 
1 GLT, 5
 
9
 
J
 
g
 
1 5
 
9-2, 59-TAACTCCAGGGAGAA-
CAGTG-39, Cg1 39-3, 59-GACAAAGGTATGTCCCAGTC-
39; for Jk1 GLT, 59Jk1 59-4, 59-CAGCAGTTCTCTGTCA-
GAGA-39, Ck 3 9-1, 59-GATGGTGGGAAGATGGATAC-39;
mMyoD 10691-F1, 59-TCTACGCACCTGGACCGCTGC-39;
mMyoD 10692-R1, 59-CAGGAGTGCCTACGGTGGTGC-
39; CD3 RT F503, 59-AAGCCTGTGACCCGAGGAAC-39;
CD3 RT R1111, 59-GTGTAACAGTCGGAGGATGG-39;
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)-S1, 59-
CCATCACCATCTTCCAGGAG-39; GAPDH-AS1, 59-CCT-
GCTTCACCACCTTCTTG-39. Numbers of PCR cycle were
as follows: 32 (Vg2 and Vg3 GLTs), 26 (Jg1 GLT), 30 (Jk1
GLT), 25 (MyoD), 23 (CD3e), and 22 (GAPDH). To specifically
amplify the spliced forms of cDNA, each LV2 and LV3 primer
was designed to span the intron between the leader and following
exons of each Vg2 and Vg3 gene. PCR products were analyzed
by Southern blotting using the following oligonucleotide as
probe: V2-39b; V3-39b; STS1008 (Jg1); 59Jk1 59-3, 59-CTT-
TCGCCTACCCACTGCTCTG-39; MyoD RT-R2, 59-CGG-
GGCTGTCTGTGGAGATGC-39; CD3 RT-F543, 59-GAGG-
GCAAAACAAGGAGCGGC-39; GAPDH-S2, 59-GGAGCCA-
AACGGGTCATCATC-39.
Chromatin Immunoprecipitation. Soluble chromatin was pre-
pared from 1–2 3 106 cells fixed with formaldehyde as described
(20, 21). The chromatin solution (2 ml) was precleared with 120
ml of 50% protein G-Sepharose slurry preadsorbed with 100 mg/
ml sonicated salmon sperm DNA (ssDNA), then aliquoted and
incubated with 4 mg of antiacetylated histone H3 antibody, 1 ml
of antiacetylated histone H4 antiserum (Upstate Biotechnology),
or 4 mg of normal rabbit IgG (Santa Cruz Biotechnology, Inc.)
overnight. Immunoprecipitates were recovered with 20 ml of
50% protein G-Sepharose/ssDNA for 2 h, washed with the buff-
ers as described (20), and resuspended in 200 ml of 10 mM Tris-
HCl, pH 8.0, 5 mM EDTA, 0.3 M NaCl, and 0.5% SDS. The
beads and an input fraction saved before preclear were incubated
at 658C for at least 6 h. DNA was purified and serial dilutions of
DNA were prepared in 25 mg/ml sonicated pBSKS and ampli-
fied as in genomic PCR for 28 cycles of 948C, 20 s, 558C, 60 s,
and 728C, 60 s with 2 s increment per each cycle using the
following primers: V2P-F1, 59-GCTCAGAACAGCTACTC-
TTC-39; V2P-R1, 59-GGATTCTCATCTGCCAGGTT-39;
V2S-F1, 59-TTGGAGGAAGAAGACGAAGC-39; V2S-R1, 59-
GGAGTGATTCAGGGGATTCA-39; V3P-F1, 59-AACAGC-
TCAGAAATAAGTCT-39; V3P-R1, 59-CTCAGGACACAA-
AAATAACG-39; V3S-F2, 59-CCACGTACTACTGTGCC-
TGC-39; V3S-R1, 59-TGACATCCTTGAACCGAGTC-39;
Jg1 59-2, 59-TAGCTCAGGTTTTCACAAGG-39; 39Jg1 39-1,
59-TCTGGAGGGAAGAAGCAATC-39; 59Jk1 59-4, 59-CAG-
CAGTTCTCTGTCAGAGA-39; 39Jk1 39-1, 59-ACAGACAT-
AGACAACGGAAG-39; MyoD-F1, 59-CGCCCTACTACAC-875 Agata et al. Brief Definitive Report
TCCTATTG-39; MyoD-R1, 59-AAGGTTCTGTGGGTT-
GGAATG-39; CD3 G1/2 F443, 59-GGCCCGGATTTCCT-
CAGTTA-39; CD3 G1/2 R636, 59-GCCATAGTAGGAT-
GAAGGAG-39. PCR products were analyzed by Southern blot-
ting using the following oligonucleotide as probe: V2P-F2,
59-TGGAAGGCGGGAGGATGAGGA-39; V2-39b (for V2S);
V3P-F2, 59-CTTCCTCCCCTGGCCCTTTGC-39; V3-39b
(for V3S); 39Jg1 39-3, 59-GACTCAGGCTAAGAATATTGT-
AGT-39; 59Jk1 59-3, 59-CTTTCGCCTACCCACTGCTCTG-
39; MyoD-F621, 59-GCCAGGACGCCCCAGGACACG-39;
CD3-F557, 59-CCTGCCTCCCCTGTCTGCTTC-39. South-
ern blots were quantitated using a Bio-image Analyzer. Quanti-
tative analysis was confirmed by comparing the dilution series.
To calculate the relative histone acetylation levels, a mean value
of the serial dilutions was calculated for the input (I) and immu-
noprecipitated (P) fractions after adjusting by the dilution factors.
The P/I ratio of each locus was then compared with that of the
positive control CD3e locus.
Results and Discussion
Histone Acetylation at Vg Genes Correlates with Accessibility
during Fetal to Adult Thymocyte Development. To investi-
gate the accessibility control of the TCR-g gene rearrange-
ment during the thymocyte development, we first assessed
the accessibility of unrearranged Vg2 and Vg3 genes by
measuring their germline transcripts in fetal and adult thy-
mocytes by reverse transcription (RT)-PCR (Fig. 1, A and
B). For adult thymocytes, we analyzed CD32CD42CD82
TN thymocytes, in which TCR-g gene rearrangements
take place. E14 thymocytes expressed both germline tran-
scripts at high levels. In E16 thymocytes, Vg3 germline
transcripts began to decline by threefold compared with
E14, whereas Vg2 germline transcripts remained compara-
ble. In contrast, germline transcripts as well as rearrange-
ments of Vg3 dramatically decreased in adult TN thy-
mocytes, whereas those of Vg2 were still predominant
(Figs. 1 B and 2 B). These results confirm the previous
findings that chromatin at Vg3 is inaccessible and Vg3 re-
arrangements are consequently inhibited in adult thy-
mocytes (13). Unrearranged Jg1 gene and CD3e gene were
vigorously transcribed in both fetal and adult thymocytes,
whereas Jk1 and MyoD were not (Fig. 1 B).
We next examined whether histone acetylation at Vg
genes correlates with accessibility. Histone acetylation was
measured by chromatin immunoprecipitation (ChIP) assay
(20, 21) using antiacetylated histone H3 and H4 antibodies.
Immunoprecipitated DNA was analyzed by quantitative
PCR to assess the association of specific DNA regions with
Figure 1. Histone acetylation at Vg genes correlates with accessibility during fetal to adult thymocyte development. (A) Schematic diagram of the
TCR-g locus and location of PCR primers used in RT-PCR and ChIP assays. The promoter (P) and RSS (S) regions of each Vg2 and Vg3 gene were
analyzed in ChIP assays. GLTs of Vg2, Vg3, and Jg1 genes were measured by RT-PCR. The Vg RSSs with 23-bp spacer and Jg1 RSS with 12-bp
spacer are indicated by filled and open triangles. (B) RT-PCR analysis of E14 and E16 total, and adult CD32CD42CD82 TN thymocyte RNA. Fivefold
serial dilutions of cDNAs and reaction without reverse transcriptase (RT2) were amplified for indicated transcripts. For Jk1 GLT and MyoD transcripts,
cDNAs from adult bone marrow and C2C12 cells were used, respectively (Control). (C) Histone acetylation measured by ChIP assay in E14 and E16 to-
tal, and adult TN thymocytes. Threefold serial dilutions of input DNA and DNAs immunoprecipitated with antiacetylated histone H3 (aAcH3) and H4
(aAcH4) antibodies or with normal rabbit IgG (Control) were analyzed by PCR. Fivefold serial dilutions of input DNA from Ba/F3 cells (Standard) and
no DNA control (DNA2) were also subjected to PCR. (D) Histone acetylation levels measured in C are shown as relative histone H3 (black bars) and
H4 (white bars) acetylation levels to that of the CD3e locus.876 Histone Acetylation Determines Accessibility for TCR-g Recombination
acetylated histones. We examined two regions correspond-
ing to the promoter and RSS for each Vg gene (Fig. 1 A).
Histone acetylation at the promoters may reflect transcrip-
tion on productively rearranged alleles. On the other hand,
PCR products of RSS regions that are deleted by recombi-
nation reflect the acetylation state before recombination.
To compensate deletions by recombination, histone acety-
lation levels were normalized with input DNA, and then
compared with that of the positive control CD3e locus.
Consistent with abundant germline transcripts, we detected
high levels of histone H3 and H4 acetylation at Vg2, Vg3,
and Jg1 in E14 thymocytes, whereas acetylation levels were
extremely low at Jk1 and MyoD (Fig. 1, C and D). We re-
producibly observed that acetylation at Vg3 promoter was
slightly higher than that of Vg2 promoter (Fig. 1 D). In
E16 thymocytes, the acetylation pattern at promoters be-
came opposite, whereas that of RSSs was unchanged (Fig.
1 D), indicating that histone acetylation at Vg3 promoter
correlates well with germline transcription during fetal
stages. Nevertheless, general acetylation levels in the pro-
moter and RSS regions are relatively high at both Vg2 and
Vg3. In contrast, acetylation levels at Vg3 promoter and
RSS specifically decreased in adult TN thymocytes,
whereas those at Vg2 and Jg1 remained relatively high
(Fig. 1 D). It might be argued that the decreased levels of
histone acetylation and germline transcription at Vg3 in
adult TN thymocytes are due to excision out of Vg3 gene
by the rearrangements of Vg2 (or Vg4) to Jg1. However,
we confirmed by Southern blotting that extrachromosomal
species were estimated to be less than one-third of Vg3
gene in adult TN thymocytes (data not shown). Thus, re-
duced histone acetylation and germline transcription at
Vg3 that we detected were not solely attributed to the ex-
cision. Furthermore, similar reduction was also found in
adult thymocytes of RAG-2 knockout mouse (data not
shown). These results indicate that histone acetylation is
tightly correlated with germline transcription and hence
accessibility on the chromosomal Vg3 gene during fetal to
adult thymocyte development. These data led us to the hy-
pothesis that histone deacetylation at Vg3 may play a role
in establishment and maintenance of the inaccessible chro-
matin structure of Vg3 gene in adult thymocytes.
Inhibition of Histone Deacetylase Induces Vg3 Rearrange-
ments in Adult-derived Thymocytes. To address this hypoth-
esis, we tested whether inhibition of histone deacetylation
by TSA (22) affects development of Vg31 T cells in FTOC
(Fig. 2 A). E14 fetal liver and adult bone marrow cells were
transferred into 29-deoxyguanosine–treated fetal thymic
lobes and then cultured with or without TSA. After 14 d,
thymocytes were prepared from the cultured lobes and an-
alyzed by flow cytometry. Both fetal liver and adult bone
marrow cells gave rise to Vg21 T cells irrespective of TSA
treatment. In contrast, a small but discrete Vg31 T cell
population was detected in fetal- but not adult-derived
thymocytes without TSA, confirming our previous finding
that the potential to differentiate into Vg31 T cells is deter-
mined at the stem cell level (14). However, in the presence
of TSA both fetal liver and adult bone marrow cells gave
rise to distinct Vg31 populations. This is not due to relative
enrichment because the absolute numbers of Vg31 cells,
but not of Vg21 cells, were significantly increased by TSA.
These data indicate that TSA treatment promotes develop-
ment of fetal-type Vg31 T cells. We also verified the donor
origin of Vg31 cells by allotypic marker (CD45.1 and
CD45.2) staining (data not shown).
To determine whether Vg3 rearrangements are also pro-
moted by TSA, we next analyzed organ-cultured thymocyte
DNA to quantitate coding joints between Vg and Jg1 exons
by PCR (Fig. 2 B). Vg2 coding joints were readily detected
in both fetal- and adult-derived thymocytes. Vg3 coding
joints were also detected in fetal-derived cells, but barely de-
tectable in adult-derived cells without TSA (Fig. 2 B, TSA2
lanes). By TSA treatment, however, Vg3 but not Vg2 cod-
ing joints were significantly increased in adult-derived cells
(5- and 17-fold on day 10 and 14, respectively, compare
TSA 1 to 2 lanes in Fig. 2 B). In fetal-derived cells, TSA
also increased Vg3 coding joints sevenfold on day 14, but
did not significantly affect them until day 10. Consistent
with the data in the flow cytometric analysis, these results
Figure 2. TSA induces Vg3 rearrangements in adult-derived thy-
mocytes. (A) Flow cytometric analysis of organ-cultured thymocytes in fe-
tal thymic lobes repopulated with E14 fetal liver and adult bone marrow
(BM) cells. Thymocytes cultured for 14 d with (1) or without (2) TSA
were stained with FITC-Vg2 and PE-CD3e, or PE-Vg3 and FITC-CD3e
antibodies. Average cell numbers per lobe from four lobes and percentages
of cells for a given phenotype are shown above and inside each panel, re-
spectively. (B) PCR analysis of organ-cultured thymocyte DNA to mea-
sure coding joints (CJ) and signal joints (SJ) of Vg2-Jg1 or Vg3-Jg1, and
CD3e gene for a control. Fivefold serial dilutions of E16 and adult TN
(ATN) thymocyte (Thy) DNA and no DNA control (DNA2) were also
subjected to PCR.877 Agata et al. Brief Definitive Report
suggest that inhibition of histone deacetylation by TSA leads
either to specific induction of Vg3 recombination or to se-
lective expansion of Vg3-rearranged cells.
To discriminate these two possibilities, we examined re-
ciprocal Vg-Jg1 signal joints that are recombination by-
products generated by joining between Vg and Jg1 RSSs
(Fig. 2 B). The amount of signal joints usually reflects de
novo recombination events, because they are present on
circular DNAs that do not replicate in most cases. Vg3 but
not Vg2 signal joints were specifically reduced in adult TN
thymocytes as well as adult-derived thymocytes without
TSA (Fig. 2 B, TSA2 lanes). However, TSA strongly in-
creased Vg3 signal joints in adult-derived cells (Fig. 2 B,
compare TSA 1 to 2 lanes). A small amount of Vg3 signal
joints was detected on day 10 without TSA, but was in-
creased sevenfold by TSA. These results demonstrate that
de novo Vg3-Jg1 recombination is induced by TSA in
adult-derived thymocytes. In addition, TSA-induced re-
combination apparently included productive Vg3-Jg1 re-
combination, as revealed by the flow cytometric analysis
(Fig. 2 A). However, it should be noted that expansion of
Vg3-rearranged cells partially contributed to the increased
Vg3 coding joints from day 10 to 14 in adult-derived cells
cultured with TSA because Vg3 signal joints reciprocally
decreased (Fig. 2 B). In fetal-derived thymocytes, high lev-
els of Vg3 coding and signal joints were detected until day
7 irrespective of TSA treatment, and then signal joints were
rapidly decreased and coding joints were also gradually re-
duced without TSA. However, TSA treatment maintained
high levels of Vg3 coding joints up to day 14 despite the
rapid loss of signal joints, indicating that TSA prolonged
the growth of Vg3-rearranged cells. This explains the ap-
parent increase of Vg31 population in fetal-derived thy-
mocytes detected by the flow cytometric analysis (Fig. 2 A).
Accessibility at Vg3 Is Increased by TSA in Adult-derived
Thymocytes. VDJ recombination is initiated by cleavages
at RSSs. We thus assessed whether TSA induces cleavages
at Vg3 RSS in adult-derived thymocytes. To this end, we
analyzed Vg signal broken ends (SBEs) in organ-cultured
thymocytes by ligation-mediated PCR (18, 23; Fig. 3 A).
SBEs are recombination intermediates produced on cleav-
age at RSSs by the RAG proteins, which directly reflect
the accessibility of RSSs (1, 2). Both Vg2 and Vg3 SBEs
were detected in E16 and fetal liver–derived thymocytes.
In contrast, Vg3 SBEs were hardly detectable in adult TN
thymocytes and adult-derived thymocytes without TSA,
whereas Vg2 SBEs were readily detected. By TSA treat-
ment, however, Vg3 SBEs were strongly induced in adult-
derived cells. This is not due to accumulation by inhibiting
joining process because the signal joints were concomi-
tantly increased (Fig. 2 B). These results demonstrate that
TSA treatment induces initiation of the recombination
event by increasing the accessibility at Vg3 RSS in adult-
derived thymocytes.
To further confirm the TSA-induced accessibility of
Vg3 chromatin, we also analyzed germline transcripts of
Vg genes in organ-cultured thymocytes by RT-PCR (Fig.
3 B). Vg3 but not Vg2 germline transcripts were specifi-
cally reduced in adult-derived cells cultured for 7 d without
TSA by threefold compared with fetal-derived cells. TSA
treatment augmented Vg3 germline transcript level three-
to fourfold. Kinetic analysis clearly showed three- to four-
fold enhancement of Vg3 germline transcription by TSA
from day 7 to 14 in adult-derived cells (Fig. 3 C). This is in
good agreement with the kinetics of Vg3 SBEs (Fig. 3 A).
Vg2 germline transcripts also increased in parallel with
SBEs from day 7 to 10 irrespective of TSA treatment, al-
though TSA slightly enhanced germline transcription (Fig.
3 C). In striking contrast to adult-derived cells, fetal-
derived thymocytes exhibited prominent germline tran-
scripts and SBEs of both Vg genes in the early phase of cul-
ture (Fig. 3, A and C), indicating that chromatin is accessible
at both Vg genes in fetal-derived cells. These data demon-
strate that TSA specifically alters Vg3 chromatin from inac-
cessible to accessible state in adult-derived thymocytes.
Histone Acetylation at Vg3 Is Increased by TSA in Adult-
derived Thymocytes. If TSA induces accessibility by directly
increasing histone acetylation, the acetylation level at Vg3
should be elevated by TSA treatment. To confirm this, we
Figure 3. Accessibility at Vg3 is increased by TSA in adult-derived
thymocytes. (A) Ligation-mediated PCR analysis of organ-cultured thy-
mocyte DNA used in Fig. 2 B to measure SBEs at Vg2 and Vg3. (B)
RT-PCR analysis of RNA prepared from fetal liver- and adult bone mar-
row (BM)-derived thymocytes cultured for 7 d with (1) or without (2)
TSA, and from E16 and adult TN (ATN) thymocytes (Thy). Fivefold se-
rial dilutions of cDNAs and reaction without reverse transcriptase (RT2)
were amplified for Vg2, Vg3 GLTs, and GAPDH transcripts. (C) Kinetic
analysis of transcript levels in organ-cultured thymocytes. Transcript levels
measured as in B are shown as the ratio to those in E16 thymocytes.878 Histone Acetylation Determines Accessibility for TCR-g Recombination
assessed histone acetylation of Vg3 chromatin in organ-cul-
tured thymocytes by ChIP assay (Fig. 4). Adult bone mar-
row–derived thymocytes cultured without TSA showed
low levels of histone H3 and H4 acetylation at Vg3,
whereas modest acetylation could be detected at Vg2 and
Jg1. TSA increased acetylation of both histone H3 and H4
at Vg3 by three- to fourfold. Acetylation levels at Vg2 and
Jg1 were slightly elevated, suggesting that TSA affects his-
tone acetylation along the entire TCR-g locus. Neverthe-
less, the most striking effect was observed at Vg3, consis-
tent with the specific enhancement of cleavage and
germline transcription at Vg3. Although elevated acetyla-
tion at Vg3 promoter may simply reflect the increased Vg3
rearrangements, similar enhancement was observed for
acetylation at Vg3 RSS as well as Vg3 germline transcrip-
tion that were derived from unrearranged alleles. These
data collectively indicate that TSA indeed increases histone
acetylation and accessibility of Vg3 chromatin, thereby in-
ducing Vg3 rearrangements in adult bone marrow–derived
thymocytes.
The accessibility model for V(D)J recombination pre-
dicts that specific modifications of chromatin at RSSs regu-
late cleavage by RAG proteins in a lineage- and stage-spe-
cific manner (3–5). Recent biochemical studies revealed
that packaging of RSSs into mononucleosomes severely in-
hibited cleavage in vitro (24, 25) and that histone acetyla-
tion did not stimulate cleavage (25) despite the functional
involvement of histone acetylation was suggested in the ac-
cessibility control in vivo (8). Thus, it has been postulated
that histone acetylation may regulate accessibility in vivo
depending on the higher order chromatin structures or
chromatin remodeling activities that are not reproduced in
vitro (8). We demonstrate here that inhibition of histone
deacetylation leads to elevated histone acetylation, accessi-
bility, and rearrangement of the Vg3 gene. Our data thus
provide evidence that histone acetylation is the chromatin
modification that triggers all the in vivo processes that in-
duce accessibility, possibly including chromatin remodel-
ing. During the preparation of our manuscript, several
studies supporting our conclusion have been reported. His-
tone deacetylase inhibition by TSA also stimulated V(D)J
recombination in cultured cell line (26) and thymocytes
of the TCR-b enhancer-deleted mice (27). Moreover,
hSWI/SNF-mediated chromatin remodeling was shown to
act in concert with histone acetylation to stimulate cleavage
on mononucleosomal DNA (28).
What is the mechanism underlying differential acetyla-
tion and accessibility in the Vg regions? The entire TCR-g
locus is hyperacetylated and accessible in fetal thymocytes,
whereas Vg3 chromatin specifically becomes hypoacety-
lated and inaccessible in adult thymocytes. Inhibition of
histone deacetylation by TSA increased transcription and
accessibility at Vg3, despite the fact that TSA does not cause
the widespread gene activation (29). These data can not be
attributed to the selective loss of factors inducing accessibil-
ity at Vg3 in adult thymocytes. Rather, they strongly sug-
gest that an active mechanism must exist to reduce the lo-
calized accessibility at Vg3. This idea is consistent with the
previous report that the Vg3 upstream sequence, when
swapped with the Vg2 upstream sequence in transgenes,
reduced rearrangements of the Vg2 gene in adult thy-
mocytes (30). A specific factor may bind to the Vg3 up-
stream sequence and recruit a histone deacetylase activity,
which reduces histone acetylation and accessibility at Vg3
chromatin. Once established, such inaccessible chromatin
probably plays a dominant role over the factors inducing
accessibility. Thus, our data imply that establishment of in-
accessible chromatin by targeted histone deacetylation may
also serve as an active and dynamic mechanism for other
developmentally regulated processes such as allelic exclu-
sion in the Ig heavy chain and TCR-b loci.
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Figure 4. Histone acetylation at Vg3 is increased by TSA in adult-derived
thymocytes. (A) Histone acetylation measured by ChIP assay in adult
bone marrow (BM)-derived thymocytes cultured for 15 days with (1) or
without (2) TSA. ChIP and PCR analysis were performed as in the leg-
end to Fig. 1 except that twofold serial dilutions of input DNA were am-
plified. (B) Histone acetylation levels in thymocytes cultured with (shaded
bars) or without (black bars) TSA measured in A are shown as relative
histone acetylation levels to that of the CD3e locus.879 Agata et al. Brief Definitive Report
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